Galderma will be highlighting its aesthetics portfolio – Restylane, Dysport (abobotulinumtoxinA) and Sculptra – and hosting a variety of activations for visitors beginning November 29th through December 4th, 2022.

Galderma is the exclusive aesthetic injectables sponsor of the 21st annual SCOPE Miami Beach 2022 art show.

Galderma will be highlighting its aesthetics portfolio – Restylane, Dysport (abobotulinumtoxinA) and Sculptra â€“ and hosting a variety of activations for visitors beginning November 29th through December 4th, 2022.

“We are thrilled to be among the artists and innovators at SCOPE Miami Beach this year,” says Carrie Caulkins, Vice President, U.S. Aesthetics Marketing, Galderma, in a news release. “Every skin story begins with a beautiful canvas and this partnership serves as a great reminder that expression can come in many forms.”

During the showcase, Galderma will create an interactive space for guests, celebrating the beauty of art and aesthetics via a custom art installation from renowned street artist, HOTTEA.  Brand representatives onsite will provide information about Restylane, Dysport and Sculptra and the booth will offer personalized consultations and real-time treatments with Miami-based aesthetic injectors, custom beauty tips and touchups from a celebrity makeup artist. 

Guests will be able to enjoy a coffee bar featuring latte art and participate in giveaways and meet and greets with A-list influencers throughout the week. Guests can also receive up to $200 off Galderma Aesthetics treatments through a special ASPIRE Galderma Rewards offer.**

“Self-expression is a cornerstone of art,” Caulkins says. “A recent study*found that the majority of consumers find it important to be able to visually express themselves, which is why, at Galderma, we embrace and encourage self-expression through the art of aesthetics. We strive to innovate and deliver products that allow patients to fully express a range of emotions, while looking their best.”

Galderma’s presence at SCOPE Miami Beach 2022 builds on the momentum of Restylane’s “XpresYourself” communications campaign, aimed at destigmatizing aesthetics and promoting natural-looking results.

SCOPE Art Show’s mission to provide a platform for experiential innovation and discovery complements Galderma’s commitment to design innovative and effective aesthetic treatments with natural-looking results for every laugh, smile and expression.

SOURCEModern Aesthetics
Previous articleEden Aesthetics distributes new radiofrequency device
Next articleCroma Australia Pty Ltd, a subsidiary of Hugel Aesthetics, Receives TGA Approval in Australia for LETYBO (letibotulinumtoxinA) for the Treatment of Glabellar Lines